These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 26932552)

  • 1. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.
    Lee MR; Rohn MC; Tanda G; Leggio L
    CNS Drugs; 2016 Feb; 30(2):109-23. PubMed ID: 26932552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxytocin in alcohol and drug abuse.
    King CE; Gano A; Becker HC
    Brain Res; 2020 Jun; 1736():146761. PubMed ID: 32142721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.
    Bowen MT; Neumann ID
    Curr Top Behav Neurosci; 2018; 35():269-287. PubMed ID: 28942596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction.
    Bowen MT; Neumann ID
    Trends Neurosci; 2017 Dec; 40(12):691-708. PubMed ID: 29128108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
    McGregor IS; Callaghan PD; Hunt GE
    Br J Pharmacol; 2008 May; 154(2):358-68. PubMed ID: 18475254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin and Rodent Models of Addiction.
    Leong KC; Cox S; King C; Becker H; Reichel CM
    Int Rev Neurobiol; 2018; 140():201-247. PubMed ID: 30193705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin for the treatment of drug and alcohol use disorders.
    Lee MR; Weerts EM
    Behav Pharmacol; 2016 Dec; 27(8):640-648. PubMed ID: 27603752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking the loop: oxytocin as a potential treatment for drug addiction.
    McGregor IS; Bowen MT
    Horm Behav; 2012 Mar; 61(3):331-9. PubMed ID: 22198308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin Signaling as a Target to Block Social Defeat-Induced Increases in Drug Abuse Reward.
    Ferrer-Pérez C; Reguilón MD; Miñarro J; Rodríguez-Arias M
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic pharmacotherapy for substance use disorder.
    Sartor GC
    Biochem Pharmacol; 2019 Oct; 168():269-274. PubMed ID: 31306644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacology of addiction--setting the scene.
    Lawrence AJ; Beart PM; Kalivas PW
    Br J Pharmacol; 2008 May; 154(2):259-60. PubMed ID: 18414384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and Addiction: Potential Glutamatergic Mechanisms.
    Sundar M; Patel D; Young Z; Leong KC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of addictive disorders.
    Ross S; Peselow E
    Clin Neuropharmacol; 2009; 32(5):277-89. PubMed ID: 19834993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin receptors in drug and alcohol addiction.
    Schank JR
    Brain Res; 2020 May; 1734():146729. PubMed ID: 32067964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
    Brabant C; Alleva L; Quertemont E; Tirelli E
    Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach to the neurobiological mechanisms of addiction.
    Fürst Z; Riba P; Al-Khrasani M
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):189-205. PubMed ID: 24380960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.
    Woolley JD; Arcuni PA; Stauffer CS; Fulford D; Carson DS; Batki S; Vinogradov S
    Psychopharmacology (Berl); 2016 Jul; 233(13):2571-80. PubMed ID: 27137199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oxytocin in the neuroadaptation to drugs of abuse.
    Sarnyai Z; Kovács GL
    Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the hormone oxytocin.
    Kovatsi L; Nikolaou K
    Vitam Horm; 2019; 111():195-225. PubMed ID: 31421701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges.
    Che X; Cai J; Liu Y; Xu T; Yang J; Wu C
    Pharmacol Ther; 2021 Jul; 223():107820. PubMed ID: 33600854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.